Efficacy of the combination therapy of Pimecrolimus 1% cream and Mometazone cream with either agent alone in the treatment of childhood vitiligo
Not Applicable
Active, not recruiting
- Conditions
- VitiligoSkin - Dermatological conditions
- Registration Number
- ACTRN12611001165976
- Lead Sponsor
- Kerman Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
No history of any kind of treatments for vitiligo since 1 month of starting the study.
Exclusion Criteria
The patients with uncontrolled systemic diseases, renal failure, autoimmune disorders, history of sensitivity to pimecrolimus cream and topical steroids/macrolides, and unstable vitiligo will be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method